Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region-Reference-Cited by-同舟云学术

Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region

Published:2020-09-03 Issue:4 Volume:268 Page:1179-1187
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Del Prete Eleonora,Francesconi Alessio,Palermo Giovanni,Mazzucchi Sonia,Frosini Daniela,Morganti Riccardo,Coleschi Piero,Raglione Laura Maria,Vanni Paola,Ramat Silvia,Novelli Alessio,Napolitano Alessandro,Battisti Carla,Giuntini Martina,Rossi Carlo,Menichetti Chiara,Ulivelli Monica,De Franco Valentino,Rossi Simone,Bonuccelli Ubaldo,Ceravolo Roberto^ORCID,

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

https://link.springer.com/content/pdf/10.1007/s00415-020-10002-6.pdf

Reference31 articles.

1. WHO Health Emergency Dashboard

2. Civile DdP. COVID-19 Italia - Monitoraggio della situazione [online]. Available at: https://opendatadpc.maps.arcgis.com/apps/opsdashboard/index.html#/b0c68bce2cce478eaac8 2fe38d4138b1.

3. ARS Toscana, Agenzia Regionale di sanità.https://www.ars.toscana.it/covid19/aggiornamenti-e-novita-sul-numero-dei-casi-per-provincia-e-per-asl-della-regione-toscana

4. Wang D, Hu B, Hu C et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA J Am Med Assoc 323:1061–1069. https://doi.org/10.1001/jama.2020.1585

5. Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does COVID-19 Trigger the Risk for the Development of Parkinson’s Disease? Therapeutic Potential of Vitamin C;Molecular Neurobiology;2023-11-14

2. SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now;Biomedicines;2023-09-13

3. The Impact of COVID-19 on Parkinson’s Disease: A Case-Controlled Registry and Questionnaire Study on Clinical Markers and Patients’ Perceptions;Acta Neurologica Scandinavica;2023-06-30

4. The Factors Associated with Internet Healthcare Service Use in China: A Qualitative Study (Preprint);2023-06-17

5. Parkinson’s disease detection using modified ResNeXt deep learning model from brain MRI images;Soft Computing;2023-05-31